Annual Revenue
$937.82 M
+$239.02 M+34.20%
31 December 2023
Summary:
PTC Therapeutics annual revenue is currently $937.82 million, with the most recent change of +$239.02 million (+34.20%) on 31 December 2023. During the last 3 years, it has risen by +$557.06 million (+146.30%). PTCT annual revenue is now at all-time high.PTCT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$196.79 M
+$10.08 M+5.40%
30 September 2024
Summary:
PTC Therapeutics quarterly revenue is currently $196.79 million, with the most recent change of +$10.08 million (+5.40%) on 30 September 2024. Over the past year, it has increased by +$210.00 thousand (+0.11%). PTCT quarterly revenue is now -35.91% below its all-time high of $307.06 million, reached on 31 December 2023.PTCT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$900.66 M
+$210.00 K+0.02%
30 September 2024
Summary:
PTC Therapeutics TTM revenue is currently $900.66 million, with the most recent change of +$210.00 thousand (+0.02%) on 30 September 2024. Over the past year, it has increased by +$102.49 million (+12.84%). PTCT TTM revenue is now -3.96% below its all-time high of $937.82 million, reached on 31 December 2023.PTCT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTCT Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.2% | +0.1% | +12.8% |
| 3 y3 years | +146.3% | +41.8% | +83.0% |
| 5 y5 years | +254.3% | +175.6% | +203.4% |
PTCT Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +146.3% | -35.9% | +41.8% | -4.0% | +83.0% |
| 5 y | 5 years | at high | +254.3% | -35.9% | +188.3% | -4.0% | +203.4% |
| alltime | all time | at high | +3614.9% | -35.9% | >+9999.0% | -4.0% | +8275.6% |
PTC Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $196.79 M(+5.4%) | $900.66 M(+0.0%) |
| June 2024 | - | $186.70 M(-11.1%) | $900.45 M(-2.9%) |
| Mar 2024 | - | $210.12 M(-31.6%) | $927.56 M(-1.1%) |
| Dec 2023 | $937.82 M(+34.2%) | $307.06 M(+56.2%) | $937.82 M(+17.5%) |
| Sept 2023 | - | $196.58 M(-8.1%) | $798.18 M(-2.5%) |
| June 2023 | - | $213.81 M(-3.0%) | $818.73 M(+6.3%) |
| Mar 2023 | - | $220.38 M(+31.6%) | $770.45 M(+10.3%) |
| Dec 2022 | $698.80 M(+29.7%) | $167.41 M(-22.9%) | $698.80 M(+0.3%) |
| Sept 2022 | - | $217.13 M(+31.2%) | $696.62 M(+12.7%) |
| June 2022 | - | $165.53 M(+11.3%) | $618.23 M(+8.6%) |
| Mar 2022 | - | $148.74 M(-10.0%) | $569.38 M(+5.7%) |
| Dec 2021 | $538.59 M(+41.4%) | $165.23 M(+19.1%) | $538.59 M(+9.4%) |
| Sept 2021 | - | $138.74 M(+18.9%) | $492.23 M(+4.3%) |
| June 2021 | - | $116.68 M(-1.1%) | $471.89 M(+9.6%) |
| Mar 2021 | - | $117.94 M(-0.8%) | $430.45 M(+13.0%) |
| Dec 2020 | $380.77 M(+24.0%) | $118.86 M(+0.4%) | $380.77 M(+6.3%) |
| Sept 2020 | - | $118.40 M(+57.4%) | $358.36 M(+15.1%) |
| June 2020 | - | $75.24 M(+10.2%) | $311.37 M(-3.2%) |
| Mar 2020 | - | $68.26 M(-29.2%) | $321.66 M(+4.8%) |
| Dec 2019 | $306.98 M(+16.0%) | $96.46 M(+35.1%) | $306.98 M(+3.4%) |
| Sept 2019 | - | $71.42 M(-16.5%) | $296.86 M(+6.4%) |
| June 2019 | - | $85.52 M(+59.6%) | $279.03 M(+6.4%) |
| Mar 2019 | - | $53.58 M(-37.9%) | $262.25 M(-0.9%) |
| Dec 2018 | $264.73 M | $86.34 M(+61.1%) | $264.73 M(+3.2%) |
| Sept 2018 | - | $53.59 M(-22.0%) | $256.43 M(+4.8%) |
| June 2018 | - | $68.74 M(+22.6%) | $244.69 M(+9.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $56.06 M(-28.2%) | $223.91 M(+15.2%) |
| Dec 2017 | $194.39 M(+135.0%) | $78.03 M(+86.4%) | $194.39 M(+37.3%) |
| Sept 2017 | - | $41.85 M(-12.7%) | $141.55 M(+15.4%) |
| June 2017 | - | $47.96 M(+80.7%) | $122.69 M(+35.8%) |
| Mar 2017 | - | $26.55 M(+5.4%) | $90.36 M(+9.3%) |
| Dec 2016 | $82.70 M(+124.9%) | $25.19 M(+9.6%) | $82.70 M(+17.7%) |
| Sept 2016 | - | $22.99 M(+47.0%) | $70.25 M(+23.2%) |
| June 2016 | - | $15.63 M(-17.3%) | $57.04 M(+18.4%) |
| Mar 2016 | - | $18.89 M(+48.4%) | $48.18 M(+31.0%) |
| Dec 2015 | $36.77 M(+45.6%) | $12.73 M(+30.3%) | $36.77 M(-3.0%) |
| Sept 2015 | - | $9.78 M(+44.3%) | $37.92 M(+31.0%) |
| June 2015 | - | $6.77 M(-9.5%) | $28.94 M(+22.7%) |
| Mar 2015 | - | $7.48 M(-46.1%) | $23.58 M(-6.6%) |
| Dec 2014 | $25.25 M(-27.2%) | $13.88 M(+1642.0%) | $25.25 M(+35.3%) |
| Sept 2014 | - | $797.00 K(-43.8%) | $18.66 M(-44.0%) |
| June 2014 | - | $1.42 M(-84.5%) | $33.32 M(-11.8%) |
| Mar 2014 | - | $9.15 M(+25.3%) | $37.77 M(+8.9%) |
| Dec 2013 | $34.70 M(+20.6%) | $7.30 M(-52.8%) | $34.70 M(+4.1%) |
| Sept 2013 | - | $15.46 M(+163.4%) | $33.31 M(+39.4%) |
| June 2013 | - | $5.87 M(-3.4%) | $23.90 M(-0.8%) |
| Mar 2013 | - | $6.07 M(+2.6%) | $24.10 M(-16.3%) |
| Dec 2012 | $28.78 M(-70.9%) | $5.92 M(-2.1%) | $28.78 M(+25.9%) |
| Sept 2012 | - | $6.04 M(-0.4%) | $22.86 M(+35.9%) |
| June 2012 | - | $6.06 M(-43.6%) | $16.82 M(+56.4%) |
| Mar 2012 | - | $10.75 M | $10.75 M |
| Dec 2011 | $98.96 M | - | - |
FAQ
- What is PTC Therapeutics annual revenue?
- What is the all time high annual revenue for PTC Therapeutics?
- What is PTC Therapeutics annual revenue year-on-year change?
- What is PTC Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for PTC Therapeutics?
- What is PTC Therapeutics quarterly revenue year-on-year change?
- What is PTC Therapeutics TTM revenue?
- What is the all time high TTM revenue for PTC Therapeutics?
- What is PTC Therapeutics TTM revenue year-on-year change?
What is PTC Therapeutics annual revenue?
The current annual revenue of PTCT is $937.82 M
What is the all time high annual revenue for PTC Therapeutics?
PTC Therapeutics all-time high annual revenue is $937.82 M
What is PTC Therapeutics annual revenue year-on-year change?
Over the past year, PTCT annual revenue has changed by +$239.02 M (+34.20%)
What is PTC Therapeutics quarterly revenue?
The current quarterly revenue of PTCT is $196.79 M
What is the all time high quarterly revenue for PTC Therapeutics?
PTC Therapeutics all-time high quarterly revenue is $307.06 M
What is PTC Therapeutics quarterly revenue year-on-year change?
Over the past year, PTCT quarterly revenue has changed by +$210.00 K (+0.11%)
What is PTC Therapeutics TTM revenue?
The current TTM revenue of PTCT is $900.66 M
What is the all time high TTM revenue for PTC Therapeutics?
PTC Therapeutics all-time high TTM revenue is $937.82 M
What is PTC Therapeutics TTM revenue year-on-year change?
Over the past year, PTCT TTM revenue has changed by +$102.49 M (+12.84%)